Expanding Japanese market entices Indian pharmaceutical firms

03/31/2013 | Business Standard (India)

India-based makers of active pharmaceutical ingredients have made inroads in the Japanese market, with seven APIs approved in Japan for Dishman Pharmaceuticals alone. Indian generic-drug makers also hope to penetrate the market as the Japanese government promotes the use of generic drugs through tax and social security reform.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC